Outcomes and risk factors of hemorrhagic cystitis in pediatric allogeneic hematopoietic stem cell transplantation recipients using different graft source and condition with severe aplastic anemia

References

• Hartung HD, Olson TS, Bessler M. Acquired aplastic anemia in children. Pediatr Clin North Am. 2013;60:1311–1336.
   PubMed Web of Science ®Google Scholar
• Kako S. [Allogeneic hematopoietic stem cell transplantation for patients with aplastic anemia]. Rinsho Ketsueki. 2020;61:1388–1394.
   PubMedGoogle Scholar
• Korthof ET, Bekassy AN, Hussein AA. Management of acquired aplastic anemia in children. Bone Marrow Transplant. 2013;48:191–195.
   PubMed Web of Science ®Google Scholar
• Young NS. Current concepts in the pathophysiology and treatment of aplastic anemia. Hematol Am Soc Hematol Educ Program. 2013;2013:76–81.
   PubMedGoogle Scholar
• Scheinberg P, Wu CO, Nunez O, et al. Long-term outcome of pediatric patients with severe aplastic anemia treated with antithymocyte globulin and cyclosporine. J Pediatr. 2008;153:814–819.
   PubMed Web of Science ®Google Scholar
• Kojima S, Horibe K, Inaba J, et al. Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation. Br J Haematol. 2000;111:321–328.
   PubMed Web of Science ®Google Scholar
• Peslak SA, Olson T, Babushok DV. Diagnosis and treatment of aplastic anemia. Curr Treat Options Oncol. 2017;18:70.
   PubMed Web of Science ®Google Scholar
• Esteves I, Bonfim C, Pasquini R, et al. Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study. Bone Marrow Transplant. 2015;50:685–689.
   PubMed Web of Science ®Google Scholar
• Kudo K, Muramatsu H, Narita A, et al. Unrelated cord blood transplantation in aplastic anemia: is anti-thymocyte globulin indispensable for conditioning? Bone Marrow Transplant. 2017;52:1659–1661.
   PubMed Web of Science ®Google Scholar
• Yagasaki H, Takahashi Y, Hama A, et al. Comparison of matched-sibling donor BMT and unrelated donor BMT in children and adolescent with acquired severe aplastic anemia. Bone Marrow Transplant. 2010;45:1508–1513.
   PubMed Web of Science ®Google Scholar
• Leung AY, Mak R, Lie AK, et al. Clinicopathological features and risk factors of clinically overt haemorrhagic cystitis complicating bone marrow transplantation. Bone Marrow Transplant. 2002;29:509–513.
   PubMed Web of Science ®Google Scholar
• Harkensee C, Vasdev N, Gennery AR, et al. Prevention and management of BK-virus associated haemorrhagic cystitis in children following haematopoietic stem cell transplantation–a systematic review and evidence-based guidance for clinical management. Br J Haematol. 2008;142:717–731.
   PubMed Web of Science ®Google Scholar
• Keles I, Bozkurt MF, Cemek M, et al. Prevention of cyclophosphamide-induced hemorrhagic cystitis by resveratrol: a comparative experimental study with mesna. Int Urol Nephrol. 2014;46:2301–2310.
   PubMed Web of Science ®Google Scholar
• Droller MJ, Saral R, Santos G. Prevention of cyclophosphamide-induced hemorrhagic cystitis. Urology. 1982;20:256–258.
   PubMed Web of Science ®Google Scholar
• Shepherd JD, Pringle LE, Barnett MJ, et al. Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation. J Clin Oncol. 1991;9:2016–2020.
   PubMed Web of Science ®Google Scholar
• Fu H, Xu L, Liu D, et al. Late-onset hemorrhagic cystitis after haploidentical hematopoietic stem cell transplantation in patients with advanced leukemia: differences in ATG dosage are key. Int J Hematol. 2013;98:89–95.
   PubMed Web of Science ®Google Scholar
• Xu LP, Zhang HY, Huang XJ, et al. Hemorrhagic cystitis following hematopoietic stem cell transplantation: incidence, risk factors and association with CMV reactivation and graft-versus-host disease. Chin Med J (Engl). 2007;120:1666–1671.
   PubMed Web of Science ®Google Scholar
• Decker DB, Karam JA, Wilcox DT. Pediatric hemorrhagic cystitis. J Pediatr Urol. 2009;5:254–264.
   PubMed Web of Science ®Google Scholar
• Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295–304.
   PubMed Web of Science ®Google Scholar
• Jagasia MH, Greinix HT, Arora M, et al. National institutes of health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 diagnosis and staging working group report. Biol Blood Marrow Transplant. 2015;21:389–401 e381.
   PubMed Web of Science ®Google Scholar
• Edenfield WJ, Moores LK, Goodwin G, et al. An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose. Bone Marrow Transplant. 2000;25:405–409.
   PubMed Web of Science ®Google Scholar
• Elfeky R, Lazareva A, Qasim W, et al. Immune reconstitution following hematopoietic stem cell transplantation using different stem cell sources. Expert Rev Clin Immunol. 2019;15:735–751.
   PubMed Web of Science ®Google Scholar
• Chang YJ, Zhao XY, Huang XJ. Immune reconstitution after haploidentical hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2014;20:440–449.
   PubMed Web of Science ®Google Scholar
• Jepsen C, Turkiewicz D, Ifversen M, et al. Low incidence of hemorrhagic cystitis following ex vivo T-cell depleted haploidentical hematopoietic cell transplantation in children. Bone Marrow Transplant. 2020;55:207–214.
   PubMedGoogle Scholar
• Annaloro C, Serpenti F, Saporiti G, et al. Viral infections in HSCT: detection, monitoring, Clinical management, and immunologic implications. Front Immunol. 2020;11:569381.
   PubMed Web of Science ®Google Scholar
• Atilla E, Atilla PA, Bozdag SC, et al. A review of infectious complications after haploidentical hematopoietic stem cell transplantations. Infection. 2017;45:403–411.
   PubMed Web of Science ®Google Scholar
• Sahin U, Toprak SK, Atilla PA, et al. An overview of infectious complications after allogeneic hematopoietic stem cell transplantation. J Infect Chemother. 2016;22:505–514.
   PubMed Web of Science ®Google Scholar
• Dosin G, Aoun F, El Rassy E, et al. Viral-induced hemorrhagic cystitis after allogeneic hematopoietic stem cell transplant. Clin Lymphoma Myeloma Leuk. 2017;17:438–442.
   PubMed Web of Science ®Google Scholar
• Lunde LE, Dasaraju S, Cao Q, et al. Hemorrhagic cystitis after allogeneic hematopoietic cell transplantation: risk factors, graft source and survival. Bone Marrow Transplant. 2015;50:1432–1437.
   PubMedGoogle Scholar
• Lam W, Storek J, Li H, et al. Incidence and risk factor of hemorrhagic cystitis after allogeneic transplantation with fludarabine, busulfan, and anti-thymocyte globulin myeloablative conditioning. Transpl Infect Dis. 2017;19:12677.
   Web of Science ®Google Scholar
• Hassan Z, Remberger M, Svenberg P, et al. Hemorrhagic cystitis: a retrospective single-center survey. Clin Transplant. 2007;21:659–667.
   PubMed Web of Science ®Google Scholar
• Karagun BS, Aygunes U, Eken A, et al. Risk assessment for BK virus-associated hemorrhagic cystitis after pediatric hematopoietic stem cell transplant: A single-center retrospective cross-sectional study. Exp Clin Transplant. 2021.
   PubMedGoogle Scholar
• Ost L, Lonnqvist B, Eriksson L, et al. Hemorrhagic cystitis–a manifestation of graft versus host disease? Bone Marrow Transplant. 1987;2:19–25.
   PubMed Web of Science ®Google Scholar
• Echavarria M, Herrera F, Solimano J, et al. Cyclic recovery of adenovirus in a stem cell transplant recipient: an inverse association with graft-versus-host disease. Bone Marrow Transplant. 2003;31:301–303.
   PubMed Web of Science ®Google Scholar
• Ruutu T, Ruutu M, Volin L, et al. Severe cystitis as a manifestation of chronic graft-versus-host disease after bone marrow transplantation. Br J Urol. 1988;62:612–613.
   PubMedGoogle Scholar
• Sawinski D, Goral S. BK virus infection: an update on diagnosis and treatment. Nephrol Dial Transplant. 2015;30:209–217.
   PubMed Web of Science ®Google Scholar
• Ambalathingal GR, Francis RS, Smyth MJ, et al. BK polyomavirus: clinical aspects, immune regulation, and emerging therapies. Clin Microbiol Rev. 2017;30:503–528.
   PubMed Web of Science ®Google Scholar